Skip to content

This website is informational for HEALTHCARE PROVIDERS only. Acyclonine MUM is only to be used and prescribed when in the opinion of the healthcare provider Acyclonine MUM is clinically significant over other commercially available products on the market.

What is Acyclonine MUM™?

Acyclovir / Triamcinolone Acetonide / Dyclonine HCI / 
Dental Powder

Acyclonine MUM may be used in the management of and for the temporary relief of symptoms as determined by the health care provider, that may be associated with Acute and Chronic Oral Mucosal Ulcerations, Oral Mucositis, Aphthous Ulcers, and ulcerative lesions resulting from trauma.

Acyclonine MUM contains:

  • Acyclovir: anti-viral for fighting infection
  • Triamcinolone Acetonide: an anti-inflammatory for reducing swelling
  • Dyclonine HCL: anesthetic numbing agent

Bottle actuator uses a patented delivery technology that allows for higher dose application and a more precise delivery to a specific area, instead of the whole mouth.

The Technology

This preparation is used by spraying medicated powder via bottle actuator onto the lesion or lesions. This medication is for intraoral use only; it is not intended for ophthalmic, nasal or dermatological use.

Warnings

If irritation develops, this medicine should be discontinued. This medication contains a corticosteroid; monitor your patient for HPA axis suppression if prolonged therapy is needed. Do not use if your patient experiences severe or troublesome adverse reactions, becomes pregnant or intends to become pregnant, or breastfeeds.

Precautions

Do not prescribe this medication if your patient has any hypersensitivities to dyclonine, acyclovir, or triamcinolone. Do not use if the patient has an active fungal or bacterial infection of the mouth or throat. A reduced dosage of dyclonine may be required in elderly patients and children.

Possible Side Effects

As reported for the individual active ingredients per scientific literature. Burning; itching; irritation; dryness; erythema; pain; stinging; blistering or peeling not present prior to therapy; perioral dermatitis; allergic contact dermatitis; maceration of the oral mucosa; hives; aphthous ulcers; secondary infection; atrophy of the oral mucosa; HPA axis suppression with systemic absorption; cardiovascular events with high plasma levels of dyclonine hydrochloride upon excessive dosage or rapid absorption; myocardium depression; hypotension; hypertension; bradycardia; cardiac arrest; drowsiness; convulsions; apprehension; euphoria; confusion; tinnitus; double vision; vomiting; twitching; sensations of heat; respiratory depression; respiratory arrest; nervousness, with excessive dosing; dizziness; blurred vision; tremors; diarrhea; nausea; sore gums.